ESC 365 - Prognostic value of liver damage assessed by direct bilirubin and skeletal muscle weakness in patients with heart failure

ESC Professional Premium Access

Prognostic value of liver damage assessed by direct bilirubin and skeletal muscle weakness in patients with heart failure

Session: Chronic heart failure - Prognosis and prediction of outcome

Topic: Rehabilitation

Speaker: Mr T. Noda (Sagamihara, JP)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Mr Takumi Noda

Kitasato University Graduate School of Medical Sciences, Sagamihara (Japan)

0 follower

8 more presentations in this session

National Early Warning Score 2 provides independent prognostic information in patients hospitalized with heart failure with preserved ejection fraction

Speaker: Doctor K. Berge (Oslo, NO)

Introduction of a new scoring tool to identify clinically stable heart failure patients

Speaker: Mr A. Gingele (Maastricht, NL)

A comprehensive study of the incremental prognostic value of novel biomarkers in PARADIGM-HF (Bio-PREDICT-HF)

Speaker: Doctor K. McDowell (Glasgow, GB)

Alkaline phosphatase and bilirubin combined are a powerful predictor of outcome in patients with heart failure and reduced ejection fraction: an analysis of the ATMOSPHERE and PARADIGM-HF trials

Speaker: Doctor C. Adamson (Glasgow, GB)

MR-proADM is a strong independent predictor of long-term all-cause mortality risk in patients with chronic heart failure: results from the E-INH study

Speaker: Doctor F. Kerwagen (Wuerzburg, DE)

Access the full session

Chronic heart failure - Prognosis and prediction of outcome

Speakers: Mr T. Noda, Doctor K. Berge, Mr A. Gingele, Doctor K. McDowell, Doctor C. Adamson...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources